FDA Panel Endorses GSK Vaccine for RSV in Older Adults, a Day After Recommending Pfizer’s Vaccine
A general view of the exterior of the GlaxoSmithKline offices in the Brentford area of London, England, on Oct. 7, 2021. (Leon Neal/Getty Images)
A general view of the exterior of the GlaxoSmithKline offices in the Brentford area of London, England, on Oct. 7, 2021. (Leon Neal/Getty Images)
GSK (GlaxoSmithKline) logo in this illustration on Aug. 10, 2022. (Dado Ruvic/Illustration/Reuters)
GSK (GlaxoSmithKline) logo on Aug. 10, 2022. (Dado Ruvic/Illustration/Reuters)